Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A modified rat model for hepatocellular carcinoma.

Fu-Chun Yang¹, Shu-Sen Zheng, Tian-An Jiang

¹Department of Hepatobiliary Pancreatic Surgery and Liver Transplantation Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

Hepatobiliary & Pancreatic Diseases International : HBPD INT

|November 30, 2004

Summary

A modified rat model for hepatocellular carcinoma (HCC) shows improved survival and general condition compared to the classical method. This enhanced model is valuable for liver cancer research and treatment development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Application of probiotic therapy in nonalcoholic fatty liver disease: mediating mechanism and future perspective.

Frontiers in cellular and infection microbiology·2025

Same author

Risk modeling of delayed postoperative bleeding after endoscopic submucosal dissection for early colorectal cancer and precancerous lesions.

World journal of gastrointestinal surgery·2025

Same author

Machine learning model stratify hepatocellular carcinoma patients into high- and low-risk recurrence or death group post curative resection.

Hepatobiliary & pancreatic diseases international : HBPD INT·2025

Same author

Epidemiological trends and burden of gallbladder and biliary tract cancer in Belt and Road Initiative countries: A comprehensive analysis from the Global Burden of Disease 2021 database.

Hepatobiliary & pancreatic diseases international : HBPD INT·2025

Same author

circ0006646 serves as a robust prognostic biomarker for post-transplant tumor recurrence and survival in hepatocellular carcinoma patients.

Hepatobiliary & pancreatic diseases international : HBPD INT·2025

Same author

Prognostic nomogram for recurrence of hepatocellular carcinoma after liver transplantation for decision making on postoperative adjuvant therapy.

Scientific reports·2025

Area of Science:

Oncology
Animal Models
Hepatology

Background:

Hepatocellular carcinoma (HCC) research benefits from accurate animal models.
Rat models are crucial for understanding liver cancer pathogenesis and evaluating treatments.
Enhancing rat physique and surgical endurance is key for model efficacy.

Purpose of the Study:

To establish a modified rat model for hepatocellular carcinoma (HCC).
To improve the general condition and surgical endurance of rats in the HCC model.
To provide a more robust model for liver cancer research.

Main Methods:

Wistar rats were administered diethylnitrosamine (DENA) via three methods over 130 days.
General conditions were evaluated using Doppler ultrasonography, laparotomy, and histopathology.

Related Experiment Videos

A modified DENA-induction protocol was compared to a classical approach.

Main Results:

The modified HCC model (group C) exhibited an 80% survival rate, with no deaths, compared to the classical model (group B) which had 6 deaths.
All surviving rats in both DENA-treated groups developed HCC and liver cirrhosis.
Rats in the modified group (C) displayed better general appearance than those in the classical group (B).

Conclusions:

The modified rat model for hepatocellular carcinoma demonstrates a high carcinogenic rate.
This enhanced model offers a high survival rate and improved general condition for surgical procedures.
The modified model is suitable for advancing liver cancer research and therapeutic strategies.